Flex Pharma Inc. (FLKS)
Symbol Info
Listed Symbol FLKS
Name Flex Pharma Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $826,955
Latest Fiscal EPS $-1.22
Price Info
21 Day Moving Average $0.5826
21 Day EMA $0.599820
50 Day Moving Average $0.5133
50 Day EMA $0.542910
200 Day EMA $0.731460
200 Day Moving Average 0.449490
52 Week High $1.49
52 Week Low $0.26
52 Week Change $-26.900398
Alpha -0.039476
Beta 1.6399
Standard Deviation 0.218691
R2 0.070959
Periods 54
Share Information
10 Day Average Volume 3,457,547
20 Day Average Volume 2,070,207
30 Day Average Volume 1,961,016
50 Day Average Volume 1,361,368
Outstanding Shares 18,069,476
Float Shares 17,539,018
Percent Float 97.06%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 55
Institute Holdings Date 2019-06-30
Institute Bought Previous 3 Months 449,261
Institute Holdings Percent 15.700000
Institute Sold Previous 3 Months 216,318
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 530,458
Price Change
7 Day Price Change $-0.2046
7 Day Percent Change -25.09%
21 Day Price Change $0.0526000
21 Day Percent Change 9.77%
30 Day Price Change $0.1089000
30 Day Percent Change 22.22%
Month To Date Price Change $0.0526
Month To Date Percent 9.77%
90 Day Price Change $0.075400
90 Day Percent Change 14.49%
Quarter To Date $0.052600
Quarter To Date Percent 9.77%
180 Day Price Change $0.275400
180 Day Percent Change 83.88%
200 Day Price Change $0.275500
200 Day Percent Change 83.93%
Year To Date $0.275500
Year To Date Percent 83.93%
Profile
Description Flex Pharma Inc is a biotechnology company. The company is engaged in developing proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions.
Details
Issue Type CS
Market Cap $10,964,558
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 18,069,476
CEO William K. McVicar
Employees 4
Last Audit UQ
Classification
CIK 0001615219
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 31 St. James Avenue
6th Floor
Boston, MA 2116
Website http://www.flex-pharma.com
Facisimile
Telephone +1 617 874-1821
Email irdept@flex-pharma.com
Key Ratios
Profitability
EBIT Margin -1,218.2
EBITDA Margin -1,196.2
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin 63.40
Profit Margin TOT -
Income Statements
Revenue $676,575
Revenue Per Share $0.0374
Revenue 3 Years $30.84
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $4,425,045
Price To Sales 16.168587
Price To Free Cash -1.2
PE High Last 5 Years -
Price To Book 1.8
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 1.8
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 6.9
Leverage Ratio 1.2
Quick Ratio 6.3
Long Term Debt To Capital -
Assets
Receivables Turnover 47.5
Invoice Turnover 1.30
Assets Turnover 0.20
Management Effectiveness
Return Assets -69.09
Return On Equity -86.19
Return On Capital -84.69
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
FLKS
FLEX PHARM..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.